Industry Reports
Novartis delivers strong financial results and four major approvals
Novartis' net sales rose 27% (+19% cc) to USD 14.9 billion. Currency benefited sales by 8% as the US dollar weakened against most currencies. Recently launched products grew 46% over the previous-year quarter, contributing USD 3.8 billion to total...
Industry Reports
Echo Therapeutics Announces First Quarter 2011 Financial Results
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the period ended March...
Industry Reports
ELC Group announces doubled revenues
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation announced today a total revenue increase of 94% for the first quarter of 2011. ELC Group published their annual results in January and predicted a gain in net revenues for the...
Industry Reports
GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March 2011. Profit after tax but before Exceptional Item grew by 16%. While the overall sales grew by 11.4%, net sales of the pharmaceuticals business...
Industry Reports
GlaxoSmithKline Pharmaceuticals profit grows by 16%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March 2011. Profit after tax but before Exceptional Item grew by 16%. While the overall sales grew by 11.4%, net sales of the pharmaceuticals business...
Industry Reports
Impax Laboratories Reports First Quarter 2011 Financial Results
Impax Laboratories, Inc.reported first quarter ended March 31, 2011 financial results. Larry Hsu, Ph.D., president and CEO, Impax Laboratories, Inc. said, Our revenue related to the sale of our generic and brand products and services other than generic Flomax(R)...
Industry Reports
IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion
The IMS Institute for Healthcare Informatics today reported a 2.3 percent increase in spending on prescription medicines in the U.S. last year, markedly lower than the 5.1 percent growth rate in 2009. In a new study, The Use of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read